Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ampliphi Biosciences
Ampliphi Biosciences
Bacteriophage Company AmpliPhi Presents Positive Data on Expanded Access Program for Serious S. aureus Infections
CP Wire
Mon, 10/8/18 - 10:03 am
Ampliphi Biosciences
AB-SA01
S. aureus
bacteriophage
Bacteriophage Company AmpliPhi Presents Positive Data on Expanded Access Program for Serious S. aureus Infections
Mon, 10/8/18 - 09:49 am
Ampliphi Biosciences
AB-SA01
S. aureus
AmpliPhi Recieves Positive FDA Feedback for its Bacteriophage Candidate AB-PA01 Development Plans Targeting Pseudomonas Aeruginosa Infections
CP Wire
Tue, 09/18/18 - 09:52 am
Ampliphi Biosciences
AB-PA01
bacteriophage
AmpliPhi Recieves Positive FDA Feedback for its Bacteriophage Candidate AB-PA01 Development Plans Targeting Pseudomonas Aeruginosa Infections
Tue, 09/18/18 - 09:53 am
Ampliphi Biosciences
AB-PA01
Bacteriophage Company Reports Success With Expanded Access Program For Resistant Infections
CP Wire
Mon, 09/17/18 - 09:55 am
bacteriophage
Ampliphi Biosciences
AB-SA01
Bacteriophage Company Reports Success With Expanded Access Program For Resistant Infections
Mon, 09/17/18 - 09:08 am
Ampliphi Biosciences
bacteriophage
AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient
CP Wire
Thu, 06/7/18 - 09:33 am
Ampliphi Biosciences
cystic fibrosis
MDR pneumonia
AB-PA01
bacteriophage
AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient
Thu, 06/7/18 - 09:20 am
Ampliphi Biosciences
bacteriophage
AB-PA01